CN106075715A - 循经护肾治疗仪 - Google Patents
循经护肾治疗仪 Download PDFInfo
- Publication number
- CN106075715A CN106075715A CN201610546575.2A CN201610546575A CN106075715A CN 106075715 A CN106075715 A CN 106075715A CN 201610546575 A CN201610546575 A CN 201610546575A CN 106075715 A CN106075715 A CN 106075715A
- Authority
- CN
- China
- Prior art keywords
- pad
- therapeutic instrument
- treatment pad
- electrode
- hours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000003734 kidney Anatomy 0.000 title claims abstract description 64
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 29
- 239000003814 drug Substances 0.000 claims abstract description 43
- 238000005452 bending Methods 0.000 claims abstract description 6
- 238000010025 steaming Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 210000000582 semen Anatomy 0.000 claims description 10
- 241000234314 Zingiber Species 0.000 claims description 7
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 7
- 235000008397 ginger Nutrition 0.000 claims description 7
- 238000001291 vacuum drying Methods 0.000 claims description 7
- 235000015099 wheat brans Nutrition 0.000 claims description 7
- 238000005253 cladding Methods 0.000 claims description 6
- 239000004744 fabric Substances 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 5
- 231100000331 toxic Toxicity 0.000 claims description 5
- 230000002588 toxic effect Effects 0.000 claims description 5
- 231100000252 nontoxic Toxicity 0.000 claims description 4
- 230000003000 nontoxic effect Effects 0.000 claims description 4
- 240000007594 Oryza sativa Species 0.000 claims description 3
- 235000007164 Oryza sativa Nutrition 0.000 claims description 3
- 238000001467 acupuncture Methods 0.000 claims description 3
- 230000001054 cortical effect Effects 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 229910052761 rare earth metal Inorganic materials 0.000 claims description 3
- 150000002910 rare earth metals Chemical class 0.000 claims description 3
- 235000009566 rice Nutrition 0.000 claims description 3
- 239000002023 wood Substances 0.000 claims description 3
- 208000017169 kidney disease Diseases 0.000 abstract description 25
- 230000000694 effects Effects 0.000 abstract description 22
- 239000000203 mixture Substances 0.000 abstract description 20
- 238000002653 magnetic therapy Methods 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 238000000015 thermotherapy Methods 0.000 abstract description 3
- 238000001827 electrotherapy Methods 0.000 abstract description 2
- 238000009434 installation Methods 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 19
- 239000008280 blood Substances 0.000 description 19
- 210000004185 liver Anatomy 0.000 description 17
- 210000000952 spleen Anatomy 0.000 description 14
- 210000002700 urine Anatomy 0.000 description 14
- 229940079593 drug Drugs 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 11
- 235000018102 proteins Nutrition 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 7
- 238000010792 warming Methods 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 230000035699 permeability Effects 0.000 description 4
- 208000037157 Azotemia Diseases 0.000 description 3
- 241000756943 Codonopsis Species 0.000 description 3
- 239000009636 Huang Qi Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 230000024924 glomerular filtration Effects 0.000 description 3
- 229930182478 glucoside Natural products 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000003907 kidney function Effects 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 230000002485 urinary effect Effects 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 2
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 208000009852 uremia Diseases 0.000 description 2
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- XFSBVAOIAHNAPC-XTHSEXKGSA-N 16-Ethyl-1alpha,6alpha,19beta-trimethoxy-4-(methoxymethyl)-aconitane-3alpha,8,10alpha,11,18alpha-pentol, 8-acetate 10-benzoate Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-XTHSEXKGSA-N 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- XFSBVAOIAHNAPC-UHFFFAOYSA-N Aconitin Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-UHFFFAOYSA-N 0.000 description 1
- 241000227129 Aconitum Species 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 241000045403 Astragalus propinquus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010041277 Sodium retention Diseases 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 241001251949 Xanthium sibiricum Species 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229940039750 aconitine Drugs 0.000 description 1
- STDXGNLCJACLFY-UHFFFAOYSA-N aconitine Natural products CCN1CC2(COC)C(O)CC(O)C34C5CC6(O)C(OC)C(O)C(OC(=O)C)(C5C6OC(=O)c7ccccc7)C(C(OC)C23)C14 STDXGNLCJACLFY-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Chemical class CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000585 glomerular basement membrane Anatomy 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 208000022182 gross hematuria Diseases 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 239000008518 lycium barbarum polysaccharide Substances 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000001055 magnesium Nutrition 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003360 nephrocyte Anatomy 0.000 description 1
- 206010029446 nocturia Diseases 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000012771 pancakes Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000014786 phosphorus Nutrition 0.000 description 1
- 229960005141 piperazine Drugs 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 231100000004 severe toxicity Toxicity 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- -1 stilbene glucoside Chemical class 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 210000003032 wing Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/002—Magnetotherapy in combination with another treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/004—Magnetotherapy specially adapted for a specific therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0625—Warming the body, e.g. hyperthermia treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
- A61M2205/051—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy
- A61M2205/052—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy infrared
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
- A61M2205/054—General characteristics of the apparatus combined with other kinds of therapy with electrotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
- A61M2205/057—General characteristics of the apparatus combined with other kinds of therapy with magnetotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1078—Urinary tract
- A61M2210/1082—Kidney
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
- A61N2005/066—Radiation therapy using light characterised by the wavelength of light used infrared far infrared
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Biomedical Technology (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Developmental Biology & Embryology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Medicines Containing Plant Substances (AREA)
- Magnetic Treatment Devices (AREA)
Abstract
本发明涉及一种护肾治疗仪,尤其是一种循经护肾治疗仪,其包括:腰背治疗垫、药袋、电极、电磁铁、控制器、腰部连接带、肩部连接带和电插头。腰背治疗垫设置电极和电磁铁,电极依照督脉经络和足太阳膀胱经络穴位排布,在腰背治疗垫外部铺敷安装药袋,药袋内填装用于治疗肾病的中药组合物;腰垫和背垫之间设置气囊,用于调节腰背治疗垫的弧度,以适应脊椎生理弯曲,达到更好的疗效。该发明将热疗、电疗、磁疗和药物导入集成于一体,综合平衡地对肾病进行治疗,效果显著。
Description
技术领域
本发明涉及护肾治疗仪,具体涉及一种循经护肾治疗仪。
背景技术
肾病初期往往都是以尿蛋白、尿潜血阳性为主的肾炎阶段;肾病的第二阶段就是肾炎得不到控制,正虚邪实进而出现肾功能下降,最终会发展到肾功能不全及尿毒症阶段。肾病发展到尿毒症后,尿毒症患者肾脏无法分清湿浊,气血淤堵,血液中肌酐、尿素氮、尿酸值不断升高,而尿量不断减少,尿色清白没有尿味,应该留在血中的精华蛋白质丢失到了尿里,应该从尿液中排出的毒素却在血液中越积越多。
循经护肾治疗仪采用的是循经护肾疗法,其工作原理是:将药物加热后,通过远红外和永磁的共同作用,将药物的有效成分送到督脉,然后使用电磁波不断地刺激任脉、足太阳膀胱经等经络参与吸收和运行,最终将药物的精华导入肾脏,达到健脾益肾、温补命门、活血化淤、祛淤生新、利水排毒来达到增加肾脏血流灌注,促进新陈代谢,改变肾脏病理结构,将肾小球基底膜清理干净,提高肾小球滤过率的目的。
目前循经护肾治疗仪多在促进药物吸收和药物组分上进行改进,其治疗功效仍有待于改进。
发明内容
本发明旨在解决上述问题,提供了一种循经护肾治疗仪,可将药物精华高效导入肾脏,激活肾脏功能,提高肾小球率过滤,使肾脏得到直接调养,其采用的技术方案如下:
一种循经护肾治疗仪,其特征在于,包括腰背治疗垫、药袋、电极、电磁铁、控制器、腰部连接带、肩部连接带和电插头,所述腰背治疗垫包括固定连接的腰垫和背垫,所述药袋铺敷安装于腰背治疗垫靠近皮肤一侧;
所述电极和电磁铁设置于腰背治疗垫内,所述电极依照督脉经络和足太阳膀胱经络的穴位排布,所述电磁铁与电极并联;
所述腰部连接带的中间通过调节扣连接,所述腰部连接带的两端与腰垫固定连接,所述肩部连接带位于背垫上部,所述肩部连接带与背垫固定连接,所述控制器设置于腰部连接带上,所述控制器的输出端与电极连接,所述控制器的输入端与电插头连接;
所述腰背治疗垫靠近皮肤的一侧采用远红外织物包覆,所述腰背治疗垫靠近外界的一侧采用皮质材料包覆。
优选地,所述腰背治疗垫设计为贴合脊柱生理弯曲的形状,所述腰垫和背垫之间的外侧设有气囊,所述气囊通过软管与手握充气球连接;所述外侧为腰背治疗垫靠近外界的一侧。
优选地,所述药袋里装有治疗肾病的中药,其各组分配方重量比如下:
以上各组分,分别粉碎至80-100目,搅拌混合均匀,装袋备用。
优选地,所述附子装袋前需要进行祛毒预处理,具体步骤包括:
(1)用清水浸泡附子四天;
(2)在烤箱中自下而上依次放置麸皮、谷糠、生姜片、附子、生姜片、谷糠、麸皮,加热至130℃,时间20~24小时;
(3)取出附子后晾晒一天,放置于木甑中连续蒸14~16小时,得到无毒附子。
优选地,所述何首乌装袋前需要进行炮制,具体步骤包括:
(1)将何首乌放置于黄酒中浸泡3小时;
(2)在蒸凝装置中从下而上依次放置何首乌、黑豆、黑芝麻,连续蒸18小时,在蒸制第6小时、第14小时的时候添加水;
(3)将蒸好的何首乌放入真空干燥箱中进行真空干燥3小时,然后再次入蒸凝装置蒸制12小时,重复该步骤3次;
(4)将步骤(3)中最后一次蒸好后的何首乌放入真空干燥箱中真空干燥3小时。
优选地,所述电磁铁为稀土永磁体。
本发明的有益效果是:
(1)本发明循经护肾治疗仪利用督脉与肾脏息息相通,同时督脉对药物吸收阻抗低,督脉脉络宽,渗透性强,通透性快的特点,通过设置电极、电磁铁刺激督脉经络和足太阳膀胱经络,有效促进药物吸收,使肾脏功能被激活,提高肾小球滤过率,恢复肾脏健康。
(2)本发明循经护肾治疗仪腰背治疗垫设计成贴合脊柱生理弯曲的形状,并且在腰垫和背垫之间设置气囊,可根据自身体型调节气囊大小,使腰背治疗垫紧紧贴合人的腰背部,使各个部位充分获得药物吸收;同时配合腰部连接带和肩部连接带,可将腰背治疗垫固定于腰背部,控制器设置于腰部连接带上,节约空间同时便于操作。
(3)本发明循经护肾治疗仪药袋中填装的中药组合物具有温肾健脾、补养肝肾、益肾润肺、气血双补和补血固精的功效,可调动人体其他器官排毒,逐渐激活和修复肾细胞;同时将具有毒性的附子进行了祛毒处理,将何首乌进行炮制使其具有补益精血的功效,进而与其它组分进行有效配伍,大大提高了产品的整体功效。
(4)本发明腰背治疗垫靠近皮肤的一侧采用远红外织物包覆,能够发射出远红外线,配合电极、电磁铁和药袋,将热疗、电疗、磁疗和药疗集成于一体,综合平衡地对肾病进行治疗。
附图说明
为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍。显而易见地,下面描述中的附图仅仅是本发明的一种实施例,对于本领域 普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据提供的附图引伸获得其它的实施附图。
图1:本发明的结构主视图。
具体实施方式
下面结合实例对本发明作进一步说明:
实施例1
如图1所示,一种循经护肾治疗仪,包括腰背治疗垫1、药袋2、电极、电磁铁3、控制器4、腰部连接带5、肩部连接带6和电插头,腰背治疗垫1包括固定连接的腰垫和背垫,药袋2铺敷安装于腰背治疗垫1靠近皮肤一侧,药袋2与腰背治疗垫1为可拆卸连接,比如通过在药袋2与腰背治疗垫1之间设置粘扣连接;
电极和电磁铁3设置于腰背治疗垫1内,电极依照督脉经络和足太阳膀胱经络的穴位排布;由于人体督脉与肾脏息息相通,并且督脉脉络宽,渗透性强,可以通过电磁铁3和电极对穴位的刺激,对周围血管的疏通,协同运作使药物通过督脉和足太阳膀胱经经由经络循环导入肾脏,使肾脏得到直接调养。
腰部连接带5的中间通过调节扣连接,腰部连接带5的两端与腰垫固定连接,肩部连接带6位于背垫上部,肩部连接带6与背垫固定连接,控制器4设置于腰部连接带5上,控制器4的输出端与电极连接,控制器4的输入端与电插头连接;使用腰部连接带5和肩部连接带6可以将腰背治疗垫1固定于背部,同时控制器4设置于腰部连接 带5上,便于操作,节省空间。使用该循经护肾治疗仪时,不必非要躺在腰背治疗垫1上才能治疗,保持坐姿依旧可以进行治疗。
腰背治疗垫1靠近皮肤的一侧采用远红外织物包覆,腰背治疗垫1靠近外界的一侧采用皮质材料包覆,远红外织物可发射远红外射线,增加皮肤通透性,增进药物吸收,皮质材料用于保温,减少热量散失,使远红外织物产生的热量只向皮肤一侧传递。
人体脊椎具有生理弯曲,平面的腰背治疗垫1往往腰部不能贴合,即使躺下也无法完全贴靠在腰背治疗垫1上,因此将腰背治疗垫1设计为贴合脊柱生理弯曲的形状,腰垫和背垫之间的外侧设有气囊7,气囊7通过软管与手握充气球连接,使用时通过;外侧为腰背治疗垫1靠近外界的一侧。
药袋2里装有治疗肾病的中药,其各组分配方重量比如下:
以上各组分,分别粉碎至80-100目,搅拌混合均匀,装袋备用。
电磁铁3为稀土永磁体。
在本发明的治疗肾病的中药组合物中,艾叶:味苦、辛,性温,归肝、脾、肾经,温经止血,散寒止痛。
在本发明的治疗肾病的中药组合物中,党参:甘,平。补中益气, 和胃生津,祛痰止咳。
在本发明的治疗肾病的中药组合物中,鹿茸:壮肾阳,补精髓,强筋骨,鹿茸中含有磷脂、糖脂、胶脂、激素、脂肪酸、氨基酸、蛋白质及钙、磷、镁、钠等成分,其中氨基酸成分占总成分的一半以上,多为人体必需氨基酸,慢性肾脏病患者体内的氨基酸比例失衡,必需氨基酸水平降低,非必须氨基酸水平升高,鹿茸可有效补充人体必需氨基酸,升高肾小球滤过率,降低尿素氮,减轻尿毒症症状。
在本发明的治疗肾病的中药组合物中,肉桂:味辛,甘,性热,属温热药,补元阳,暖脾胃,除积冷,通血脉。肉桂甘热而益火消阴,能温营血,能走能守,又能引火归元,宜治下焦虚寒证。肉桂从肾排出而致局部刺激,具有利尿作用,与附子、熟地配伍使用,动静结合,具有温肾的强大作用。
在本发明的治疗肾病的中药组合物中,赤芍:味苦,性微寒,归肝经。具有清热凉血,活血化瘀的功效,促进血液循环,增强药物吸收。
在本发明的治疗肾病的中药组合物中,杜仲:味甘,温,归肝、肾经。杜仲游离氨基酸极少,含有的少量蛋白质,是和绝大多数食品类似的完全蛋白,即能够水解检出人体必需的8种氨基酸,以备尿毒症患者机体的正常代谢。
在本发明的治疗肾病的中药组合物中,何首乌:苦甘涩,微温,入脾、肺、肾三经,何首乌主要含三类有效成分:二苯乙烯苷类化合物、蒽醌类化合物及聚合原花青素,此外还含有卵磷脂和多种微量元 素,二苯乙烯苷类化合物是一类具有显著药理活性的水溶性成分,其代表成分二苯乙烯苷,具有显著的降脂作用,有利于对肝脏的保护。何首乌为生熟异治中药,生何首乌有清热解毒的功效,炮制后的熟何首乌有补益精血、黑发的作用。在使用何首乌前需要对其进行炮制,具体包括以下步骤:
(1)将何首乌放置于黄酒中浸泡3小时;
(2)在蒸凝装置中从下而上依次放置何首乌、黑豆、黑芝麻,连续蒸18小时,在蒸制6小时、14小时的时候添加水;
(3)将蒸好的何首乌放入真空干燥箱中进行真空干燥3小时,然后再次入蒸凝装置蒸制12小时,重复该步骤3次;
(4)将步骤(3)中最后一次蒸好后的何首乌放入放入真空干燥箱中真空干燥3小时,即得具有补益精血功效的何首乌。
黄酒用于引导何首乌药效发生变化,黑豆、黑芝麻为入肾经药物,可增强何首乌补肾的功能,蒸制6小时、14小时的时候添加水,可以保持水量的充足,保证何首乌的蒸制效果。采用真空干燥而非晾晒的方式,其一是为了避免何首乌被空气中的微生物污染,其二可以加快干燥进度,缩短炮制时间。
在本发明的治疗肾病的中药组合物中,黄芪:味甘,气微温,气薄而味浓,可升可降,阳中之阳也,无毒。专补气。黄芪粉大鼠口服对注射免抗鼠肾血清造成的肾毒血清性肾炎有明显的治疗作用,能显著减少尿中蛋白的量。
在本发明的治疗肾病的中药组合物中,附子:味辛、甘,有毒, 入心、脾、肾经,通行十二经,附子辛苦热燥烈,走而不守,能回阳救逆、温里助阳、祛寒止痛。附子是植物乌头的子根,其富含的乌头碱有剧毒。附子一般在产地以盐水浸泡祛毒,然而依然有残余毒性,因此,本发明采用煨法祛毒,具体步骤包括:
(1)用清水浸泡附子四天;
(2)在烤箱中自下而上依次放置麸皮、谷糠、生姜片、附子、生姜片、谷糠、麸皮,加热至130℃,时间20~24小时;
(3)取出附子后晾晒一天,放置于木甑中连续蒸14~16小时,得到无毒附子。
在烤箱中各种组分的放置顺序,是为了保证附子位于中间层,从附子层向外依次被生姜片、谷糠和麸皮包裹,烤箱可上、下面均进行加热,加热的时候可使附子层两面接受高温煨制,提高煨制效率,缩短煨制时间。
在本发明的治疗肾病的中药组合物中,菟丝子:归肾、肝、脾经,气和性缓,能浮能沉,具有滋补肝肾、固精缩尿的功效,与茯苓、莲子配伍,健脾止泻,辅佐黄芪、党参可起益气健脾之效。
在本发明的治疗肾病的中药组合物中,熟地:味甘,微温,归肝、肾经,补血养阴,填精益髓。
在本发明的治疗肾病的中药组合物中,桑叶:味苦、甘、性寒,归肺、肝经,入足太阳膀胱经,除水肿,利五脏,桑叶有抑制脂肪肝的形成、降低血清脂肪和抑制动脉粥样硬化形成的作用,桑叶中含有强化毛细血管、降低血液黏度的黄酮类成分,对高脂血症血清脂质升高及动脉粥样硬化有抑制作用,协同枸杞可滋养肝肾。
在本发明的治疗肾病的中药组合物中,茯苓:味甘淡,性平,入心、肺、脾、肾经,茯苓可影响肾小管对钠离子的重吸收,具有利尿、健脾和宁心安神的功效,对于脾虚不运的水肿具有治疗效果,茯苓配附子、黄芪和党参,温肾利水,增强健脾益气和利水消肿的功效,补而不滞,其协同作用比单味药持续作用更强。
在本发明的治疗肾病的中药组合物中,枸杞:味甘、性平、归肝、肾经,具有滋补肝肾的功效,枸杞中含有的枸杞多糖能通过阻止内质网的损伤,促进蛋白质合成,并具有解毒作用,可恢复肝细胞的功能,促进肝细胞再生。枸杞和熟地性味归经相似,功效相近,皆为补血、滋补肝肾之品,共同用于血虚肝肾阴亏诸症,相辅为用。熟地专入肝肾,枸杞功逊熟地,二者协同作用,可补肝肾,入肝肾经,兼入肺经。
在本发明的治疗肾病的中药组合物中,莲子:味甘、涩、平,归心、脾、肾、胃、肝、膀胱经,具有补脾止泻、益肾固精、养心安神的功效。
实施例2:
一种循经护肾治疗仪,其结构和连接关系同实施例1,不同的是药袋里治疗肾病的中药,其各组分配方重量如下:
以上各组分,分别粉碎至80-100目,搅拌混合均匀,装袋备用。
实施例3
不同的是药袋里治疗肾病的中药,其各组分配方重量如下:
以上各组分,分别粉碎至80-100目,搅拌混合均匀,装袋备用。
本发明循经护肾治疗仪于2015年至2016年临床治疗肾病患者50例,临床报告如下:
1、一般资料
50例患者中,男27例,女23例,年龄35岁~60岁,病程2年~10年。
2、诊断标准
2.1尿常规检查结果有血尿(镜下及肉眼血尿)、蛋白尿或管型尿(如红细胞管型、颗粒管型等);
2.2常有高血压及水钠潴留症状(如水肿等),有时有短暂的氮质血症;
证候:肾阳虚:神疲乏力、精神不振、活力低下、易疲劳;畏寒怕冷、四肢发凉(重者夏天也凉)、身体发沉;腰膝酸痛、腰背冷痛、 筋骨萎软;性功能减退、阳痿、早泄、易患前列腺炎等;小便清长、余沥不尽、尿少或夜尿频多;纳呆腹胀,精神萎靡,肌肤甲错,面色灰暗;出现尿蛋白、水肿、高血压。
3、治疗方法
每日采用循经护肾治疗仪治疗一次,每次1小时,7天为1疗程,连续治疗4个疗程。
使用步骤:将循经护肾治疗仪治疗贴放于背部,用腰部连接带和肩部连接带固定于身上,接通电源,将控制器开关设置于“开”位置,选择治疗时间为1小时,热疗与磁疗操作下,开始15~30分钟设置在最高功效。
4、疗效评定:
4.1治愈:
头晕、贫血、心慌胸闷、疲倦乏力、恶心呕吐、食欲不振、出汗及其它不适感觉消失。
尿常规检查结果:尿白细胞(-),尿蛋白(-),尿红细胞(-),红细胞管型(-),颗粒管型(-),尿比重1.010~1.030,pH值5.5~7.5。
4.2好转:尿白细胞、尿蛋白、尿红细胞、红细胞管型和颗粒管型,由阳性转为弱阳性。
4.3未愈:尿白细胞、尿蛋白、尿红细胞、红细胞管型或颗粒管型检测仍为阳性。
5、治疗效果:
结果:50例患者中,临床治愈:35例,好转:12例,未愈:3 例。
上面以举例方式对本发明进行了说明,但本发明不限于上述具体实施例,凡基于本发明所做的任何改动或变型均属于本发明要求保护的范围。
Claims (6)
1.一种循经护肾治疗仪,其特征在于,包括腰背治疗垫(1)、药袋(2)、电极、电磁铁(3)、控制器(4)、腰部连接带(5)、肩部连接带(6)和电插头,所述腰背治疗垫(1)包括固定连接的腰垫和背垫,所述药袋(2)铺敷安装于腰背治疗垫(1)靠近皮肤一侧;
所述电极和电磁铁(3)设置于腰背治疗垫内,所述电极依照督脉经络和足太阳膀胱经络的穴位排布,所述电磁铁(3)与电极并联;
所述腰部连接带(5)的中间通过调节扣连接,所述腰部连接带(5)的两端与腰垫固定连接,所述肩部连接带(6)位于背垫上部,所述肩部连接带(6)与背垫固定连接,所述控制器(4)设置于腰部连接带(5)上,所述控制器(4)的输出端与电极连接,所述控制器(4)的输入端与电插头连接;
所述腰背治疗垫(1)靠近皮肤的一侧采用远红外织物包覆,所述腰背治疗垫(1)靠近外界的一侧采用皮质材料包覆。
2.根据权利要求1所述的循经护肾治疗仪,其特征在于,所述腰背治疗垫(1)设计为贴合脊柱生理弯曲的形状,所述腰垫和背垫之间的外侧设有气囊(7),所述气囊(7)通过软管与手握充气球连接;所述外侧为腰背治疗垫(1)靠近外界的一侧。
3.根据权利要求1或2所述的循经护肾治疗仪,其特征在于,所述药袋(2)里装有治疗肾病的中药,其各组分配方重量比如下:
以上各组分,分别粉碎至80-100目,搅拌混合均匀,装袋备用。
4.根据权利要求3所述的循经护肾治疗仪,其特征在于,所述附子装袋前需要进行祛毒预处理,具体步骤包括:
(1)用清水浸泡附子四天;
(2)在烤箱中自下而上依次放置麸皮、谷糠、生姜片、附子、生姜片、谷糠、麸皮,加热至130℃,时间20~24小时;
(3)取出附子后晾晒一天,放置于木甑中连续蒸14~16小时,得到无毒附子。
5.根据权利要求4所述的循经护肾治疗仪,其特征在于,所述何首乌装袋前需要进行炮制,具体步骤包括:
(1)将何首乌放置于黄酒中浸泡3小时;
(2)在蒸凝装置中从下而上依次放置何首乌、黑豆、黑芝麻,连续蒸18小时,在蒸制第6小时、第14小时的时候添加水;
(3)将蒸好的何首乌放入真空干燥箱中进行真空干燥3小时,然后再次入蒸凝装置蒸制12小时,重复该步骤3次;
(4)将步骤(3)中最后一次蒸好后的何首乌放入真空干燥箱中真空干燥3小时。
6.根据权利要求3所述的循经护肾治疗仪,其特征在于,所述电磁铁(3)为稀土永磁体。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610546575.2A CN106075715B (zh) | 2016-07-12 | 2016-07-12 | 循经护肾治疗仪 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610546575.2A CN106075715B (zh) | 2016-07-12 | 2016-07-12 | 循经护肾治疗仪 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106075715A true CN106075715A (zh) | 2016-11-09 |
CN106075715B CN106075715B (zh) | 2017-07-18 |
Family
ID=57221257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610546575.2A Active CN106075715B (zh) | 2016-07-12 | 2016-07-12 | 循经护肾治疗仪 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106075715B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107693350A (zh) * | 2017-11-22 | 2018-02-16 | 高建平 | 一种气垫式电发热督灸治疗带 |
CN107744461A (zh) * | 2017-11-22 | 2018-03-02 | 高建平 | 一种仰卧式电热督灸治疗装置 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1102131A (zh) * | 1993-11-01 | 1995-05-03 | 锦州市微电子电热技术开发公司 | 腰脱综合治疗仪 |
CN1143502A (zh) * | 1993-11-10 | 1997-02-26 | 吴新光 | 一种祛病回春固本延寿新药 |
CN1196922A (zh) * | 1997-04-18 | 1998-10-28 | 丁永庆 | 穴位定位、刺激保健带 |
CN1555895A (zh) * | 2003-12-30 | 2004-12-22 | 王铁民 | 肾病、尿毒症治疗仪及其配套药物组合物 |
CN201510499U (zh) * | 2009-11-04 | 2010-06-23 | 王世义 | 新型理疗靠背架 |
CN201996800U (zh) * | 2010-11-24 | 2011-10-05 | 李强 | 砭石医疗保健养生带 |
-
2016
- 2016-07-12 CN CN201610546575.2A patent/CN106075715B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1102131A (zh) * | 1993-11-01 | 1995-05-03 | 锦州市微电子电热技术开发公司 | 腰脱综合治疗仪 |
CN1143502A (zh) * | 1993-11-10 | 1997-02-26 | 吴新光 | 一种祛病回春固本延寿新药 |
CN1196922A (zh) * | 1997-04-18 | 1998-10-28 | 丁永庆 | 穴位定位、刺激保健带 |
CN1555895A (zh) * | 2003-12-30 | 2004-12-22 | 王铁民 | 肾病、尿毒症治疗仪及其配套药物组合物 |
CN201510499U (zh) * | 2009-11-04 | 2010-06-23 | 王世义 | 新型理疗靠背架 |
CN201996800U (zh) * | 2010-11-24 | 2011-10-05 | 李强 | 砭石医疗保健养生带 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107693350A (zh) * | 2017-11-22 | 2018-02-16 | 高建平 | 一种气垫式电发热督灸治疗带 |
CN107744461A (zh) * | 2017-11-22 | 2018-03-02 | 高建平 | 一种仰卧式电热督灸治疗装置 |
CN107693350B (zh) * | 2017-11-22 | 2024-07-26 | 佑兰熙(上海)医疗科技有限公司 | 一种气垫式电发热督灸治疗带 |
Also Published As
Publication number | Publication date |
---|---|
CN106075715B (zh) | 2017-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11701401B2 (en) | Herbal composition in powder, pill or liquid form for speeding up fracture healing and bone regeneration and herbal formulation in powder, pill or liquid form containing the same | |
CN103006979B (zh) | 一种治疗肾病水肿的内服中药组合物 | |
CN102430079A (zh) | 一种治疗淋证的中药组合物 | |
CN104013825A (zh) | 一种治疗糖尿病的中药组合物 | |
CN103638250B (zh) | 一种治疗面神经麻痹的中药制剂及其制备方法 | |
CN109730692A (zh) | 一种2型糖尿病五阶段分级监测模板及营养素中药组合 | |
CN104232443A (zh) | 一种增强人体免疫力的药酒 | |
CN106728386A (zh) | 一种调理气血,调经养颜膏滋及其制备方法 | |
CN106075715A (zh) | 循经护肾治疗仪 | |
CN107789521A (zh) | 一种缓解眼疲劳、治疗近视的复方中药组合物眼贴 | |
CN107496585A (zh) | 一种具有温肾壮阳、补中健脾作用的足浴药包 | |
CN101428114B (zh) | 一种治疗慢性乙肝、肝硬化和肝腹水的药物 | |
CN101301432B (zh) | 一种治疗脑出血的中药组合物 | |
CN103463588A (zh) | 一种治疗中气下陷的中药组合物 | |
CN107349413A (zh) | 一种以生姜为原料的泡脚配方 | |
CN104043095B (zh) | 治疗浅表性胃炎并反流性食管炎的中药颗粒及其制备方法 | |
CN101357208A (zh) | 一种治疗慢性浅表性胃炎的中药组合物 | |
CN101116710A (zh) | 一种治疗产后小便不通的中药制剂 | |
CN110237199A (zh) | 一种用于降血糖的穴位贴膏剂、制备方法及应用 | |
CN103816425A (zh) | 一种用于治疗老年性痴呆的中药及其制备方法 | |
CN107397622A (zh) | 用于治疗骨病的热疗床及其使用方法 | |
CN106963856A (zh) | 平衡阴阳针结合电针治疗脑卒中痉挛性偏瘫的中药导入液 | |
CN105327194A (zh) | 一种治疗贫血的药物及其制备方法 | |
CN104758539A (zh) | 一种治疗乏力的中药组合物 | |
CN105079476A (zh) | 改善产后无乳的专用药膳 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |